• Immunome Chief Business Officer Horn Kinney sold 90,616 common shares on Aug. 4 at a weighted average USD 25.09.
• Sale followed option exercises totaling 90,616 shares at USD 12.92 and USD 10.6.
• Horn Kinney’s direct common stock holding fell to 0 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunome Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001831215-26-000005), on August 06, 2026, and is solely responsible for the information contained therein.